FDA Approves New Antibiotic for Drug-Resistant UTIs

The U.S. Food and Drug Administration has authorized Zaynich, an intravenous antibiotic, for treating complicated urinary tract infections caused by susceptible gram-negative bacteria. This approval offers a new option against multidrug-resistant pathogens, supported by trial data showing high efficacy. It addresses a growing challenge in infectious disease treatment.